We are live on ! Find out more
IRAG

Investment Research & Advisory Group Portfolio holdings

AUM $324M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+22.57%
3 Year Est. Return
+88.65%
5 Year Est. Return
+107.32%
10 Year Est. Return
–
AUM
$134M
AUM Growth
-$4.64M
Cap. Flow
+$4.3M
Cap. Flow %
3.22%
Top 10 Hldgs %
51.75%
Holding
183
New
6
Increased
38
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.24M
2
DAL icon
Delta Air Lines
DAL
+$1.08M
3
BND icon
Vanguard Total Bond Market
BND
+$653K
4
CHH icon
Choice Hotels
CHH
+$627K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$304K

Top Sells

Rank Stock Value
1
PFNX
Pfenex Inc.
PFNX
+$3.45M
2
LYFT icon
Lyft
LYFT
+$93K
3
META icon
Meta Platforms (Facebook)
META
+$72.1K
4
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$47.2K
5
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$45.1K

Sector Composition

Rank Sector Weight
1 Technology 19.12%
2 Financials 17.95%
3 Healthcare 12.47%
4 Consumer Discretionary 7.6%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
76
Mondelez International
MDLZ
$78.5B
$88K 0.07%
1,607
– –
ABT icon
77
Abbott
ABT
$188B
$86K 0.06%
888
– –
BMY icon
78
Bristol-Myers Squibb
BMY
$132B
$83K 0.06%
1,170
– –
CL icon
79
Colgate-Palmolive
CL
$74.3B
$82K 0.06%
1,171
– –
D icon
80
Dominion Energy
D
$59.1B
$81K 0.06%
1,165
-287
-20% -$23.2K
MHK icon
81
Mohawk Industries
MHK
$9.19B
$80K 0.06%
875
– –
DUK icon
82
Duke Energy
DUK
$94.5B
$76K 0.06%
820
-213
-21% -$22.9K
ENB icon
83
Enbridge
ENB
$112B
$76K 0.06%
2,045
– –
O icon
84
Realty Income
O
$58.6B
$76K 0.06%
1,300
– –
IBB icon
85
iShares Biotechnology ETF
IBB
$9.82B
$75K 0.06%
642
– –
BSV icon
86
Vanguard Short-Term Bond ETF
BSV
$45.6B
$74K 0.06%
991
– –
PNC icon
87
PNC Financial Services
PNC
$100B
$73K 0.05%
488
– –
ESGR
88
DELISTED
Enstar Group
ESGR
$62K 0.05%
363
– –
BNDX icon
89
Vanguard Total International Bond ETF
BNDX
$82.8B
$61K 0.05%
1,278
– –
AMD icon
90
Advanced Micro Devices
AMD
$767B
$56K 0.04%
890
– –
WFC icon
91
Wells Fargo
WFC
$265B
$54K 0.04%
1,345
– –
C icon
92
Citigroup
C
$227B
$53K 0.04%
1,268
– –
EW icon
93
Edwards Lifesciences
EW
$53B
$50K 0.04%
600
– –
MINT icon
94
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
$48K 0.04%
484
-455
-48% -$45.1K
MO icon
95
Altria Group
MO
$109B
$48K 0.04%
1,197
– –
APD icon
96
Air Products & Chemicals
APD
$68.6B
$43K 0.03%
185
– –
GS icon
97
Goldman Sachs
GS
$301B
$41K 0.03%
139
– –
TD icon
98
Toronto Dominion Bank
TD
$200B
$41K 0.03%
667
– –
AA icon
99
Alcoa
AA
$13.6B
$34K 0.03%
1,019
– –
CHKP icon
100
Check Point Software Technologies
CHKP
$13.4B
$34K 0.03%
300
– –
2 3
4
5 6

Similar funds

AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return

Investment Research & Advisory Group's Q3 2022 Portfolio in Review

As of Q3 2022, Investment Research & Advisory Group held 183 positions worth $134M, down 3.4% from $138M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Investment Research & Advisory Group deployed $4.3M of net new capital in Q3 2022, opening 6 new positions and adding to 38 existing holdings. Its largest new stake was Pfizer: 66,725 shares worth $2.92M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $72.1K trimmed.

  • Investment Research & Advisory Group's largest Q3 2022 buy was Pfizer: 66,725 shares worth $2.92M.
  • Investment Research & Advisory Group added most to Vanguard Total Bond Market in Q3 2022, an estimated $653K increase.
  • Investment Research & Advisory Group's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $72.1K.
  • Investment Research & Advisory Group fully exited Pfenex Inc. in Q3 2022, selling an estimated $3.45M.
  • Investment Research & Advisory Group's ten largest holdings make up 52% of its $134M portfolio in Q3 2022.
  • Investment Research & Advisory Group opened 6 new positions and closed 11 in Q3 2022.
  • Investment Research & Advisory Group's portfolio value fell 3.4% quarter-over-quarter to $134M.

Based on Investment Research & Advisory Group's 13F filing for Q3 2022, filed 18 Oct 2022.